SEC Form 4
MacroGenics, Inc. (MGNX) insider trading
In the 12 months to Oct 26, 2026, one MGNX insider reported open-market sales of $129.1K across 1 filing; no open-market purchases were filed.
Latest filing · Last 12 months · Source: SEC EDGAR · How we count
- Open-market sales
- $129.1K
- 1 filing · 1 insider
- Open-market purchases
- $0
- 0 filings
- Pre-arranged sales (10b5-1)
- 1 of 1
- All $129.1K sold was pre-arranged
Who traded MGNX, and when
- Sale
- Sale, pre-arranged (10b5-1)
MGNX daily close from Oct 27, 2025 to Oct 26, 2026, between $1.33 and $4.86, last $2.19. 1 sale and 0 purchase filings by 1 insider, marked at their filing dates. Jeffrey Stuart Peters, Senior VP, GC, and Secretary: sold $129.1K across 1 filing, first filed Aug 20, 2026, last Aug 20, 2026.
Largest mark · tap a row for others
Jeffrey Stuart Peters · Senior VP, GC, and Secretary
Sale $129,086
31,105 shares at $4.15 avg
Filed Aug 20, 2026 · traded Aug 19
Pre-arranged (10b5-1) · close on filing date $4.07
Jeffrey Stuart Peters · Senior VP, GC, and Secretary
Senior VP, GC, and Secretary
$129.1K soldOpen-market trades
1 filing in the last 12 months| Insider | Role | Sold | Bought | Filings | Pre-arranged (10b5-1) | Last filed |
|---|---|---|---|---|---|---|
| Jeffrey Stuart Peters | Senior VP, GC, and Secretary | $129.1K | — | 1 | 100% of sales |
| Filed | Insider | Type | Shares | Avg price | Value | Held after | Source |
|---|---|---|---|---|---|---|---|
traded | Jeffrey Stuart Peters Senior VP, GC, and Secretary | SalePre-arranged (10b5-1) | 31,105 | $4.15 | $129.1K | 0 |
GET /stocks/filings/vX/form-4?tickers=MGNX&filing_date.gte=2025-10-26&sort=filing_date.desc&limit=500{
"status": "OK",
"results": [
{
"tickers": [
"MGNX"
],
"issuer_cik": "0001125345",
"owner_cik": "0001706903",
"accession_number": "0001706903-26-000006",
"form_type": "4",
"filing_date": "2026-08-20",
"period_of_report": "2026-08-19",
"issuer_name": "MACROGENICS INC",
"issuer_trading_symbol": "MGNX",
"owner_name": "Peters Jeffrey Stuart",
"is_director": false,
"is_officer": true,
"is_ten_percent_owner": false,
"is_other": false,
"officer_title": "Senior VP, GC, and Secretary",
"security_type": "non_derivative",
"record_type": "transaction",
"security_title": "Common Stock",
"transaction_timeliness": "O",
"aff_10b5_one": true,
"transaction_date": "2026-08-19",
"transaction_code": "S",
"equity_swap_involved": false,
"transaction_shares": 31105,
"transaction_price_per_share": 4.15,
"transaction_acquired_disposed": "D",
"shares_owned_following_transaction": 0,
"transaction_value": 129085.75000000001,
"not_subject_to_section_16": false,
"direct_or_indirect": "D",
"footnotes": [
{
"id": "F1",
"description": "The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the reporting person on May 20, 2026."
},
{
"id": "F2",
"description": "This transaction was executed in multiple trades at prices ranging from $4.12 to $4.24. The reporting person undertakes to provide to MacroGenics, Inc., any security holder of MacroGenics, Inc., or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range."
}
]
}
]
}
// trimmed to 1 resultsThe response includes every Form 4 record; this page keeps open-market purchases and sales on common stock and removes duplicate joint-filer rows.
Other insider activity (not market trades) · 49 records
- Option exercises31 records
- Tax withholding18 records
Reported on Form 4 but not purchases or sales in the market, so not counted in the totals above.
How to read this page
- Open-market purchase or sale
- A buy or sell of the company's stock at market price. Grants, option exercises, shares withheld for tax, gifts and employee stock plan purchases are listed separately and not counted.
- Pre-arranged (10b5-1)
- The insider marked the filing as made under a trading plan set up in advance (SEC Rule 10b5-1). The mark covers the whole filing, and an unmarked filing may still be under a plan.
- Filing date
- Insiders have two business days to report a trade. Totals and the chart use the filing date, when the trade became public.
Frequently asked questions
Has MacroGenics, Inc.'s CEO sold stock?
No. Eric Blasius Risser (CEO) made no open-market sales filed as CEO in the last 12 months.
How current is MGNX’s insider data?
These are MGNX Form 4 filings from the last year, refreshed daily. The Massive Form 4 API has the full, continuously updated record.
What counts as an open-market buy or sell?
Only purchases and sales at the market price. Option exercises, grants, gifts, and shares withheld for taxes are reported on Form 4 but are left out of the buy and sell totals.
Build with AI
Track MGNX insider trades with your agent
This page joins two Massive endpoints: Form 4 filings and daily prices. Ask an agent to watch for new filings:
Using the Massive API (massive.com/docs/llms.txt), check Form 4 filings for MGNX every day with transaction_code=P and tell me when an insider files an open-market purchase, with their role, shares, price and the filing link.
Nothing on this page is investment advice. All data and content is provided for informational purposes under our Terms of Service.